Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

U.S. Attempts to Get Its Xylazine Problem Under Control

In February, we reported on the emerging problem of xylazine-laced fentanyl. In this report, we follow up on what has happened since doctors first started raising concerns about this contaminant and its effects. Early in 2023, word started to spread among physicians that a veterinary tranquilizer called xylazine — also known as “tranq” — was […]

Opinion | The Medical System Is Failing Black Kids With Severe Mental Illness

My Black patient spent most of February in a locked inpatient psychiatric ward. Well, he wasn’t my patient anymore, but he had been at one time. As a resident working with hospitalized children with severe mental illnesses, he was one of my very first patients. He helped me to become a better doctor. I wish […]

Opinion | Annual Check-Up: Mark Cuban’s Cost Plus Drugs

On February 16, 2022, medical student Jared Dashevsky shared his perspective on Mark Cuban’s new business endeavor, the Cost Plus Drug Company. As part of MedPage Today‘s review of the past year’s top events, Dashevsky follows up with his thoughts on how the company is doing nearly 1 year post-launch and where it may be […]

DBN Health News